Status:
UNKNOWN
Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography
Lead Sponsor:
Aiden Abidov
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
This study is for people who have a SPECT scan (nuclear imaging of the blood flow to the heart muscle) ordered by their medical doctors. As part of the SPECT scan, they will have been given a drug cal...
Detailed Description
This is a single center, prospective, non-randomized, comparative, same-setting study of Lexiscan MPI SPECT versus state-of-the-art echocardiography. Lexiscan SPECT MPI will be performed per routine c...
Eligibility Criteria
Inclusion
- Patients referred to a University of Arizona/Sarver Heart Center/University Medical Center stress imaging laboratory and scheduled to receive a regadenoson SPECT nuclear scan.
Exclusion
- Patients unable or unwilling to undergo the clinically necessary stress test or to provide informed consent.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT01150578
Start Date
December 1 2011
End Date
December 1 2015
Last Update
November 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona Medical Center
Tucson, Arizona, United States, 85724